Status:
WITHDRAWN
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
Lead Sponsor:
Zeng Changhao
Conditions:
Dysphagia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to explore Clinical Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease. The main question it aims to answer is...
Detailed Description
Gastroesophageal reflux is a common digestive disorder characterized by the backflow of stomach contents and fluids into the esophagus. The goal of this clinical trial is to explore Clinical Effect o...
Eligibility Criteria
Inclusion
- Meeting the diagnostic criteria for Gastroesophageal Reflux Disease.
- Age between 18 and 65 years.
- Confirmed tongue-pharyngeal nerve injury by electromyography.
- Esophageal manometry and barium swallow examination confirming the presence of pharyngeal dysphagia.
- Normal higher brain function, able to cooperate with treatment.
Exclusion
- Brain vascular disease diagnosed.
- Clinical assessment and swallowing videofluoroscopic examination revealing cognitive phase, oral preparatory phase, or oral phase disorders.
- Concurrent presence of other neurological disorders such as Alzheimer's disease, traumatic brain injury, Parkinson's disease.
- Esophageal obstruction and severe liver or kidney dysfunction
- Subjective unwillingness to undergo the treatment and presence of psychiatric abnormalities, etc.
Key Trial Info
Start Date :
January 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06215794
Start Date
January 30 2024
End Date
May 15 2024
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zheng Da First Yuan Hospital
Zhengzhou, Henan, China, 450000